Lymphadenectomy Clinical Trials

Clinical trials related to Lymphadenectomy Procedure

Image-guided Lymphadenectomy Within Urologic Regions of Interest in AMIGO

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This research study involves the use of two navigation systems, the 3D Slicer-based navigation system, and the Siemens Monaco systems, to simplify the complexity of image-guided lymphadenectomy procedures (surgery to remove one or more lymph nodes) in patients with urological cancer.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Signed written informed consent before any trial-related procedure is undertaken that is not part of the standard patient management

• Subjects aged ≥ 18 years. Selected patients must have a confirmed or suspected diagnosis of disease in urologic regions of interest, with scheduled confirmatory surgical biopsy.

• Subjects must have had a CT, PET or MR examination of acceptable quality at Brigham and Women's Hospital within the prior month.

• Subjects must also be scheduled to undergo lymphadenectomy for a urologic cancer within the following urologic regions of interest: Bladder, Prostate, Testicular, Kidney, Urethral, and Penile.

• Subjects must also be scheduled to undergo a laparoscopic lymphadenectomy within the AMIGO OR

Locations
United States
Massachusetts
Brigham and Women's Hospital
RECRUITING
Boston
Contact Information
Primary
Matthew Mossanen, MD
mmossanen@bwh.harvard.edu
(617) 732-6384
Time Frame
Start Date: 2022-04-01
Estimated Completion Date: 2026-09-01
Participants
Target number of participants: 20
Treatments
Experimental: Urologic Lymphadenectomy in AMIGO
Participants will undergo Lymphadenectomy per standard of care with the navigation systems (3D Slicer and Monaco) used to locate the abnormal lymph node(s).
Related Therapeutic Areas
Sponsors
Leads: Brigham and Women's Hospital

This content was sourced from clinicaltrials.gov